Search

everythinglearnresearchcommunity

for

Search:↓

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Conditions affecting sex development show that sexual diversity is a natural part of human variation.

Balding and low testosterone increase risk of urinary stones.

Spironolactone is effective for idiopathic hirsutism but has limited effects on other PCOS symptoms.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Hormone levels in hair vary across the head, with the highest concentration of a key hormone linked to hair loss at the top.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Hormone therapy might help improve women's appearance as they age.

Low estrogen compared to androgen may cause female hair loss.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

150 kHz electromagnetic radiation may improve polycystic ovary condition in rats.

Segmental hair analysis can track testosterone over time but needs adjustments for sex, hair color, and washing frequency.

Finasteride use may be linked to rare testicular tumor, but more research needed.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Finasteride's negative effects on brain tissue in male rats may be reversible after stopping the drug.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Metformin is less effective in men with early-onset hair loss.